Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
489
-
Total 13F shares, excl. options
-
97,569,996
-
Shares change
-
+3,504,058
-
Total reported value, excl. options
-
$11,099,337,871
-
Value change
-
+$397,513,543
-
Put/Call ratio
-
118%
-
Number of buys
-
226
-
Number of sells
-
227
-
Price
-
$113.87
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q4 2018
As of 31 Dec 2018 RESMED INC - Common Stock (RMD) had 583 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 97,569,996 shares of stock of the company.
Largest 10 holders included Vanguard Group Inc, BlackRock Inc., FMR LLC, Capital World Investors, STATE STREET CORP, BAILLIE GIFFORD & CO, WCM INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and JPMORGAN CHASE & CO.
This table shows 583 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.